BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+8.61%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$1.87B
AUM Growth
+$1.87B
(+1.8%)
Cap. Flow
-$66.3M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
83.98%
Holding
25
New
1
Increased
9
Reduced
6
Closed
2
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$25.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$24.8M |
| 3 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.33M |
| 4 |
Neurocrine Biosciences
NBIX
|
$6.5M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.41M |
Top Sells
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$42.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$31.3M |
| 3 |
Incyte
INCY
|
$27.5M |
| 4 |
OPTR
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
|
$17.9M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$15.7M |
Sector Composition
| 1 | Healthcare | 87.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $343M | 18.32% |
2,029,271
+30,000
| +2% | +$5.07M |
|
2
Gilead Sciences
GILD
$140B
| $266M | 14.23% |
3,547,714
-80,000
| -2% | -$6.01M |
|
|
3
Ionis Pharmaceuticals
IONS
$6.79B
| $256M | 13.66% |
6,417,548
-785,037
| -11% | -$31.3M |
|
|
4
Incyte
INCY
$16.5B
| $214M | 11.42% |
4,221,087
-542,183
| -11% | -$27.5M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $104M | 5.58% |
1,404,445
| – | – |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $101M | 5.38% |
757,428
| – | – |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $94.4M | 5.05% |
1,479,706
+30,000
| +2% | +$1.91M |
|
8
Halozyme
HALO
$8.56B
| $70.8M | 3.78% |
4,724,936
-791,386
| -14% | -$11.9M |
|
|
PCYC
9
DELISTED
PHARMACYCLICS INC
PCYC
| $67.3M | 3.6% |
636,542
+237,512
| +60% | +$25.1M |
|
|
GEVA
10
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $55.6M | 2.97% |
858,757
+144,155
| +20% | +$9.33M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $52.8M | 2.82% |
192,000
+90,000
| +88% | +$24.8M |
|
|
IMGN
12
DELISTED
Immunogen Inc
IMGN
| $47.3M | 2.53% |
3,225,816
-50,000
| -2% | -$734K |
|
13
Innoviva
INVA
$1.29B
| $31.7M | 1.69% |
888,244
| – | – |
|
14
Alnylam Pharmaceuticals
ALNY
$58.5B
| $30.3M | 1.62% |
471,288
| – | – |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $29.4M | 1.57% |
488,188
+106,302
| +28% | +$6.41M |
|
|
ECYT
16
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $28.2M | 1.51% |
2,643,522
+374,177
| +16% | +$4M |
|
|
17
Neurocrine Biosciences
NBIX
$13.8B
| $24.7M | 1.32% |
2,646,552
+696,404
| +36% | +$6.5M |
|
|
INFI
18
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $18M | 0.96% |
1,300,737
| – | – |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $13.3M | 0.71% |
471,282
+97,982
| +26% | +$2.77M |
|
|
ARIA
20
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $9.46M | 0.51% |
1,387,171
-2,301,900
| -62% | -$15.7M |
|
|
IDIX
21
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $7.48M | 0.4% |
1,250,000
| – | – |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.91M | 0.32% |
1,779,340
| – | – |
|
|
OPTR
23
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| – | – |
-1,422,200
| Closed | -$17.9M |
|
|
ONXX
24
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| – | – |
-339,870
| Closed | -$42.4M |
|